Nakarai et al. evaluated the mRNA expression of ELF3 and carcinoembryonic antigen (CEA) in the lymph node and the tissue from patients with colorectal cancer (CRC) and controls. This evidence concerns the gene CEACAM5 and colorectal carcinoma.